Nuclea Biotechnologies' Series B - III Round

Nuclea Biotechnologies raised a round of funding on February 02, 2012.

Nuclea Biotechnologies is a healthcare company dedicated to the development and commercialization of clinical diagnostic assays identifying gene and protein expression profiles characteristic of an in…

Articles about Nuclea Biotechnologies' Series B - III Round: